Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03177876
Other study ID # cebc.cairo university
Secondary ID
Status Active, not recruiting
Phase N/A
First received May 19, 2017
Last updated June 5, 2017
Start date July 2016
Est. completion date July 2017

Study information

Verified date June 2017
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

twenty recruited patients indicated for sinus augmentation and immediate implant placement will be divided into two groups (10 in each of the two groups), to compare bone formation and implant stability after shneiderian membrane elevation and augmentation with Hydroxyapatite Nano particles [Nanostreams] or augmentation with graft less tenting technique with simultaneous implant placement.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 20
Est. completion date July 2017
Est. primary completion date June 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Patients with atrophic maxilla and pneumatization of the maxillary sinus with residual bone height at least 5mm of residual ridge as per MISCH criteria

- Both sexes

Exclusion Criteria:

- Sinus pathology

- Heavy smokers more than 20 cigarettes per day

- Patients with systemic disease that may affect normal healing

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
sinus lift implant placement Hydroxyapatite Nano particles
shneiderian membrane elevation and augmentation with Hydroxyapatite Nano particles with simultaneous implant placement
sinus lift implant placement tenting
shneiderian membrane elevation and augmentation with graft less tenting technique with simultaneous implant placement

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Outcome

Type Measure Description Time frame Safety issue
Primary patient satisfaction evaluation of post operative complications in terms of pain and edema using patient pain chart 7 days post operative
Secondary implant stability measurement of the implant stability using osstell device will be measured intra-operative after implant insertion and will be measured one more time 6 months after the first operation at the time of implant exposure
Secondary height of bone gain or loss around the implant two cone beam CT will be taken for the patients, one immediate post operative and the other 6 months post-operative then the amount of bone gained or loss will be assessed by superimposing the same section in the two cone beam CT 6 months post operative
See also
  Status Clinical Trial Phase
Completed NCT05777239 - Dental Implant Approach for Crestal Sinus Elevation; A Novel Technique. N/A
Not yet recruiting NCT03731650 - Non-grafted Maxillary Sinus Floor Elevation With Simultaneous Implant Placement Using Different Implant Lengths N/A
Recruiting NCT04688957 - Osseodensification by Densah Burs Versus Osteotome N/A